Examination of the mechanism of antibody formation using nucleic acid and protein inhibitors.
D000818:Animals; D000917:Antibody Formation; D001769:Blood; D002701:Chloramphenicol / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology*; D007108:Immune Tolerance; D066298:In Vitro Techniques; D008727:Methotrexate / Q000494:pharmacology*; D051379:Mice; D011691:Puromycin / Q000494:pharmacology*; D012333:RNA, Messenger; D013307:Streptomycin / Q000494:pharmacology*; D013745:Tetanus Toxoid / Q000494:pharmacology*
D012333:RNA, Messenger; D013745:Tetanus Toxoid; D003609:Dactinomycin; D011691:Puromycin; D004917:Erythromycin; D002701:Chloramphenicol; D013307:Streptomycin; D008727:Methotrexate